LifeScan Global Corp., the glucose-monitor maker backed by private equity firm Platinum Equity, filed for
- The plan has the backing of 97% of the company’s secured creditors. It will see debt cut by more than 75% and will allow the company to continue operating normally during its Chapter 11 case.
- Alongside $667 million of financial debt, LifeScan reported more than $1 billion of outstanding rebate claims on its balance sheet. These originated from agreements with US pharmacy benefit managers, state Medicaid entities, and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.